Creative Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-100
Closed -$2K 1951
2017
Q2
$2K Buy
+100
New +$16.3K ﹤0.01% 4277
2017
Q1
Sell
-1,100
Closed -$19K 4629
2016
Q4
$19K Buy
1,100
+1,000
+1,000% +$151K ﹤0.01% 3111
2016
Q3
$1K Sell
100
-400
-80% -$67.6K ﹤0.01% 4343
2016
Q2
$3K Hold
500
﹤0.01% 3850
2016
Q1
$4K Hold
500
﹤0.01% 3667
2015
Q4
$9K Hold
500
﹤0.01% 3341
2015
Q3
$5K Buy
+500
New +$78.8K ﹤0.01% 3579

Other funds holding AMGN

Creative Planning's AMGN Position: Q1 2026 in Review

Creative Planning increased its Amgen (AMGN) stake by 10% in Q1 2026, buying an estimated $8.36M and bringing the position to 246,914 shares worth $86.9M. The position accounts for 0.06% of the portfolio, ranked #144.

Creative Planning first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Creative Planning held 246,914 shares of Amgen worth $86.9M as of Q1 2026.
  • Creative Planning bought 23,462 Amgen shares in Q1 2026, an estimated $8.36M.
  • Amgen made up 0.06% of Creative Planning's portfolio in Q1 2026, its #144 holding.
  • Creative Planning first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.